MCHP
34
-2
WEC
53
5
CVS
41
-4
MAS
52
-4
GT
56
-3
GRMN
67
-4
XYL
35
-2
RL
69
-4
ORCL
63
-4
AME
74
-4
WAT
48
-11
NI
72
4
PAYX
48
-6
ICE
59
-3
AON
54
2
OMC
50
-16
MO
60
-2
HSY
31
-6
YUM
43
-6
ABT
59
2
MCHP
34
-2
WEC
53
5
CVS
41
-4
MAS
52
-4
GT
56
-3
GRMN
67
-4
XYL
35
-2
RL
69
-4
ORCL
63
-4
AME
74
-4
WAT
48
-11
NI
72
4
PAYX
48
-6
ICE
59
-3
AON
54
2
OMC
50
-16
MO
60
-2
HSY
31
-6
YUM
43
-6
ABT
59
2
Financhill
Back

BNY Mellon Core Bond ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
21

BKAG
BNY Mellon Core Bond ETF

Last Price:
41.60
Seasonality Move:
0.46%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
21
BNY Mellon Core Bond ETF (BKAG) is a Sell

Is BNY Mellon Core Bond ETF a Buy, Sell or Hold?

  • The current BNY Mellon Core Bond ETF [BKAG] share price is $41.59. The Score for BKAG is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BKAG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKAG Stock Price Chart

What is BNY Mellon Core Bond ETF's stock price today?

  • The BNY Mellon Core Bond ETF share price today is $41.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKAG is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BKAG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 35.03 Sell
Chaikin Money Flow: 21880 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.69 - 42.29) Sell
Bollinger Bands (100): (41.79 - 43.01) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BKAG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.72 Sell
20-day SMA: 41.87 Sell
50-day SMA: 42.53 Sell
200-day SMA: 41.9 Sell
8-day EMA: 41.7 Sell
20-day EMA: 41.9 Sell
50-day EMA: 42.23 Sell
200-day EMA: 42.05 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BNY Mellon Core Bond ETF Earnings Growth & BKAG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BNY Mellon Core Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):